Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference
-
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Canaccord Genuity 43rd Annual Growth Conference
-
Upwork to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Viant to Present at an Upcoming Investor Conference
-
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Plans to Participate in Annual Canaccord Genuity Growth Conference
-
CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Bionano to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Avalyn Pharma Invited to Present at Canaccord Genuity Annual Growth Conference
-
Form 8.3 - [EMIS Group plc - 26 07 2023] - (CGWL)
-
Cybin to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference
-
Intention to launch an offer for subscription
-
Arrow Announces Ian Langley Has Been Appointed to the Board of Directors
-
Arrow Announces CN-2 Well Results Exceed Expectations in Ubaque Formation
-
Semrush Holdings, Inc. to Participate in Upcoming Investor Conferences
-
TransMedics to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Standard BioTools to Participate in Upcoming Investor Conferences
-
Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
EverQuote to Participate in Upcoming Investor Conferences
-
Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
illumin Announces Substantial Issuer Bid and Provides Second Quarter Guidance
-
Concentrix to Present at Canaccord Genuity 43rd Annual Growth Conference
-
Interim Management Statement
-
Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference
-
Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
-
Hudson Technologies to Attend 43rd Annual Canaccord Genuity Growth Conference
-
Lucid Diagnostics to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
LSI Industries to Attend the 43rd Annual Canaccord Genuity Growth Conference
-
Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
BlackBerry to Participate in Upcoming Investor Events
-
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
-
Form 8.3 - [EMIS Group plc - 25 07 2023] - (CGWL)
-
Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth Conference
-
Pliant Therapeutics to Participate in Upcoming Investor Conferences
-
Form 8.3 - [EMIS Group plc - 24 07 2023] - (CGWL)
-
Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 8, 2023, and Announces Participation in Upcoming Investor Conference
-
Allied Gold Corp Limited, Allied Merger Corporation and Mondavi Ventures Ltd. Announce Equity Financing Terms and Allocation of Private Placement
-
Health Catalyst to Participate in Upcoming Investor Conference
-
JFrog to Present at Upcoming Investor Conferences
-
Arcturus Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 7, 2023
-
ATEC to Participate in Upcoming Investor Conferences
-
Aurora Announces Closing of $820 Million Upsized Public Offering and Private Placement of Class A Common Stock
-
Onyx Gold Announces Trading Debut and Introduces Executive Team and Exploration Plans
-
Form 8.3 - [EMIS Group plc - 21 07 2023] - (CGWL)
-
AtriCure to Participate at Upcoming Investor Conferences
-
CANACCORD GENUITY GROUP INC. ACCESS TO FIRST QUARTER FISCAL 2024 RESULTS INFORMATION
-
Form 8.3 - [EMIS Group plc - 19 07 2023] - (CGWL)

